Neoadjuvant Chemotherapy for Locally Advanced T4 Colon Cancer: A Nationwide Propensity-Score Matched Cohort Analysis
Open Access
- 29 October 2019
- journal article
- research article
- Published by S. Karger AG in Digestive Surgery
- Vol. 37 (4) , 292-301
Abstract
Introduction: Neoadjuvant chemotherapy (CT) for locally advanced colon cancer (LACC) could potentially lead to tumor shrinkage, eradication of micrometastases, and prevention of tumor cell shedding during surgery. This retrospective study investigates the surgical and oncological outcomes of preoperative CT for LACC. Methods: Using the Netherlands Cancer Registry, data of patients with stage II or III colon cancer, diagnosed between 2008 and 2016 was collected. A propensity score matching (PSM; 1:2) was performed and compared patients with clinical tumor (cT) 4 colon cancer who were treated with neoadjuvant CT to patients with cT4 colon cancer treated with adjuvant CT (Fig. 1). Results: A total of 192 patients treated with neoadjuvant CT were compared to 1,954 patients that received adjuvant CT. After PSM, 149 patients in the neoadjuvant group were compared to 298 patients in the control group. No significant differences were found in baseline characteristics after PSM. After neoadjuvant CT, a significant response was observed in 13 (9%) patients with 5 (4%) patients showing a complete response. Complete resection margins (R0) were achieved in 77% in the neoadjuvant group versus 86% in the adjuvant treated group (p = 0.037). Significantly less tumor positive lymph nodes were found in the neoadjuvant group (median 0 vs. 2, p < 0.001). Major complication rates and 5-year overall survival did not differ between both groups (67–65%, p = 0.87). Conclusion: Neoadjuvant CT seems safe and feasible with similar long-term survival compared to patients who are treated with adjuvant CT.Keywords
This publication has 37 references indexed in Scilit:
- Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgeryClinical and Translational Oncology, 2016
- Adjuvant chemotherapy is not associated with improved survival for all high‐risk factors in stage II colon cancerInternational Journal of Cancer, 2016
- Lymph node identification following neoadjuvant therapy in rectal cancer: A stage‐stratified analysis using the surveillance, epidemiology, and end results (SEER)‐medicare databaseJournal of Surgical Oncology, 2015
- Variations in Metastasis Site by Primary Location in Colon CancerJournal of Gastrointestinal Surgery, 2015
- Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastasesClinical & Experimental Metastasis, 2015
- Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factorInternational Journal of Cancer, 2014
- Neoadjuvant chemoradiotherapy and multivisceral resection for primary locally advanced adherent colon cancer: A single institution experienceEuropean Journal of Surgical Oncology, 2012
- Tumour seeding in peritoneal wound sites in relation to growth-factor expression in early granulation tissueEuropean Journal of Cancer, 2004
- Metastatic Tumor Doubling Time: Most Important Prehepatectomy Predictor of Survival and Nonrecurrence of Hepatic Colorectal Cancer MetastasisWorld Journal of Surgery, 2004
- Growth rate of hepatic metastases in colorectal carcinomaBritish Journal of Surgery, 1988